Multi‐Omic Analysis Reveals the Impact of Bortezomib in Hyperleukocytic Acute Myeloid Leukemia

ABSTRACT Background Hyperleukocytic acute myeloid leukemia (HL‐AML) is associated with early complications and high mortality rates, highlighting the urgent need for more effective therapeutic strategies. Methods This study conducted label‐free proteomic analysis on serum from HL‐AML and non‐HL AML...

Disgrifiad llawn

Manylion Llyfryddiaeth

Prif Awduron:	Jinxian Wu, Xinqi Li, Bei Xiong, Wanyue Yin, Ruihang Li, Guopeng Chen, Linlu Ma, Xiqin Tong, Xiaoyan Liu, Fuling Zhou
Fformat:	Artigo
Iaith:	Inglês
Cyhoeddwyd:	Wiley 2024-11-01
Cyfres:	Cancer Medicine
Pynciau:	bortezomib hyperleukocytic acute myeloid leukemia NF‐kappa B pathway proteomics
Mynediad Ar-lein:	https://doi.org/10.1002/cam4.70438
Tagiau:	Ychwanegu Tag Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!